Sep 2026· International Journal of Dermatology· Vol 65, pp. S46 - S51· 1 citation· 39 references
Medicine
TL;DR
This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image-based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools.
Abstract
Accurate diagnosis and risk stratification are central for optimal management of patients with melanoma. Current American Joint Committee on Cancer (AJCC) staging systems inadequately stratify patients with clinically meaningful metastatic potential. Manual histopathologic interpretation compounds this limitation, particularly for diagnostically ambiguous lesions at the benign‐malignant interface, where concordance is highly variable. This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image‐based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools. We review published DL models applied to hematoxylin and eosin whole‐slide images (H&E WSIs) for melanoma diagnosis, subtype classification, and survival prediction, and discuss integration with transcriptomic and spatial proteomic data modalities. Computational pathology, informed by deep learning, can reliably identify melanomas at risk of disease recurrence and progression. These inferences can be enhanced by integration of spatial molecular profiling, which can also provide mechanistic explainability to the H&E‐based DL models. However, limitations in dataset diversity, external validation, model interpretability, and generalizability across populations and image acquisition protocols currently prevent clinical adoption. Outcome‐anchored, multimodal computational pathology pipelines integrating H&E WSIs with spatial multi‐omic profiling offer a biologically grounded and scalable framework for personalized risk stratification in stage I‐III CM, with potential to standardize diagnosis, discover novel prognostic features, and inform individualized treatment strategies.
Cutaneous melanoma (CM) is a highly aggressive form of skin cancer requiring accurate subtype classification for effective prognosis and treatment. To address the scarcity of high-quality datasets, we curated 82 Hematoxylin & Eosin (H&E)-stained whole slide images (WSIs) from 32 patients in the Clinical Proteomic Tum...
Seongho Yoon, Byungeun Shon, So-yeon Kim et al.· Scientific Data· 0 citations
Purpose Differentiating between a choroidal melanoma and metastatic carcinoma to the choroid on cytological specimens presents significant diagnostic challenges due to subtle morphological differences in the sparse cells available in the sample and the increasing scarcity of specialist ocular pathologists. This study d...
Maxine Jackson, H. Kalirai, Rumana N. Hussain et al.· Investigative Ophthalmology...· 0 citations
Background/Objectives: Lymph-node metastasis remains central to staging, prognosis, surveillance, and treatment planning in malignant melanoma. At present, most statistical models assessing nodal metastatic risk in malignant melanoma consider pathological descriptors, inflammatory markers, metabolic alterations, clinic...
V. Atanasescu, V. Grigorean, R. Tulin et al.· Journal of Clinical Medicine· 0 citations
A comprehensive overview of the current state and future perspectives of AI in management of cutaneous melanoma is provided, enabling the extraction of morphological and spatial features that are imperceptible to the human eye.
C. Bossard, Y. Salhi, J. Chetritt· Presse medicale· 0 citations
Related blog posts
Microsoft Research Blog· microsoft.comNov 16, 2026
AI coding agents are increasingly help developers fix bugs and build features largely on their own, but every interaction with their models consumes tokens. In each session, an agent sends instructions, tool descriptions, and session history to its model. Most efforts to reduce this cost focus on individual tasks. Yet developers return to the same […] The post TokenEconomizer: Learning from Experience to Make AI Coding Agents More Efficient appeared first on Microsoft Research.
At ICSOB 2026 in Gothenburg, we presented TenderIntell, our work on multi-agent support for tendering. This post looks back at the conference, the idea behind a panel of three AI reviewers who score each proposal independently, and why evaluating agents reliably is the question we keep coming back to. The post TenderIntell at ICSOB 2026: Three Days in Gothenburg appeared first on GPT-Lab.
MIT News · Artificial Intelligence· news.mit.eduNov 13, 2026
Founded by Anthony Jules ’92, SM ’92 and Professor Emeritus Rodney Brooks, Robust AI’s robots are designed to collaborate with humans in factories and warehouses.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.